Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT02924038
Title A Study of Varlilumab and IMA950 Vaccine Plus Poly-ICLC in Patients With WHO Grade II Low-Grade Glioma (LGG)
Recruitment Terminated
Gender both
Phase Phase I
Variant Requirements No
Sponsors Nicholas Butowski
Age Groups: senior | adult
Covered Countries USA

No variant requirements are available.